Clinical Efficacy and Safety of Ixekizumab for Treatment of Psoriasis A. Azevedo, T. Torres

Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis: Subgroup analysis of Latin American patients in the phase 3 randomized UNCOVER-3 study F. Valenzuela, C. de la Cruz Fernandez, R.L. Galimberti, S. Gürbüz, M. McKean-Matthews, L. Goncalves, R. Romiti

Long-Term Real-World Persistence of Guselkumab in Patients With Moderate-to-Severe Psoriasis J. Borrás-Blasco, R. Alcala, A. Valcuende-Rosique, S. Cornejo